Tamparong, Bernabe, Jr. P.
HRN: 18-32-79 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2026
CEFTAZIDIME 1GM (VIAL)
01/11/2026
01/18/2026
IV
1g
Q8H
CAP MR
Checking Initial Appropriateness
01/12/2026
CEFTAZIDIME 1GM (VIAL)
01/12/2026
01/19/2026
IV
1g
Q48 Post HD
CAP MR
Checking Initial Appropriateness